Obesity drug giant Eli Lilly on Thursday reported a monster first quarter, fortifying our conviction to stick with the stock after a period of sluggishness.
Read more
Verify All Oil Trade Documents
Obesity drug giant Eli Lilly on Thursday reported a monster first quarter, fortifying our conviction to stick with the stock after a period of sluggishness.
Read moreIn this article AMZN CSCO AAPL GOOGL HPQ MSFT DELL Follow your favorite stocksCREATE FREE ACCOUNT Intel’s CEO Lip-Bu Tan speaks at the company’s Annual
Read more